Efficacy of single-dose cholecalciferol in the blood pressure of patients with type 2 diabetes, hypertension and hypovitaminoses D
Tatiana P de Paula, Juliano S R Moreira, Luiza F Sperb, Maria Elisa P Muller, Thais Steemburgo, Luciana V Viana, Tatiana P de Paula, Juliano S R Moreira, Luiza F Sperb, Maria Elisa P Muller, Thais Steemburgo, Luciana V Viana
Abstract
Observational and experimental data reinforce the concept that vitamin D is associated with the pathogenesis of arterial hypertension. We investigated the effect of a single dose of 100,000 IU of cholecalciferol, in office blood pressure (BP), and 24-h ambulatory blood pressure monitoring (ABPM) in patients with type 2 diabetes mellitus (DM), hypertension, and hypovitaminosis D. Forty-three patients were randomized to a placebo or cholecalciferol group. BP was assessed by office measurements and 24-h ABPM, before and after intervention. At week 8, a greater decrease in median ABPM values was observed in cholecalciferol supplementation than in the placebo group for systolic 24-h (- 7.5 vs. - 1; P = 0.02), systolic daytime (- 7 vs. - 1; P = 0.007), systolic nighttime (- 7.0 vs. 3; P = 0.009), diastolic 24-h (- 3.5 vs. - 1; P = 0.037), and daytime DBP (- 5 vs. 0; P = 0.01). Office DBP was also reduced after vitamin D supplementation. A single dose of vitamin D3 improves BP in patients with type 2 diabetes, hypertension, and vitamin D insufficiency, regardless of vitamin D normalization. Vitamin D supplementation could be a valuable tool to treat patients with type 2 DM, hypertension, and hypovitaminosis D.Trial registration: Clinicaltrials.gov NCT02204527.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
- McGreevy C, Williams D. New insights about vitamin D and cardiovascular disease. Ann. Intern. Med. 2011;155:820–882. doi: 10.7326/0003-4819-155-12-201112200-00004.
- Grossman H. Ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Diabetes Care. 2013;36(suppl 2):307–331. doi: 10.2337/dcS13-2039.
- Ke L, Mason RS, Kariuki M, Mpofu E, Brock KE. Vitamin D status and hypertension: a review. Integr. Blood Press Control. 2015;8:13–35.
- Mirhosseini N, Vatanparast H, Kimball SM. The Association between Serum 25(OH)D status and blood pressure in participants of a community-based prog. Nutrients. 2017;9(11):E1244. doi: 10.3390/nu9111244.
- Li YC. Vitamin D: roles in renal and cardiovascular protection. Curr. Opin. Nephrol. Hypertens. 2012;21:72–79. doi: 10.1097/MNH.0b013e32834de4ee.
- Zhang W, Chen L, Zhang L, et al. Administration of exogenous 1,25(OH)2D3 normalizes overactivation of the central renin-angiotensin system in 1α(OH)ase knockout mice. Neurosci. Lett. 2015;19(588):184–189. doi: 10.1016/j.neulet.2015.01.013.
- Witham M, Adnan Nadir M, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 2009;27:1948–1954. doi: 10.1097/HJH.0b013e32832f075b.
- Beveridge LA, Struthers AD, Khan F, et al. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA. 2015;175(5):745–754.
- Paula TP, Kramer CK, Viana LV, Azevedo MJ. Effects of individual micronutrients on blood pressure in patients with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. Sci. Rep. 2017;7:40. doi: 10.1038/srep40751.
- Vimaleswaran KS, Cavadino A, Berry DJ, et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2014;2(9):719–729. doi: 10.1016/S2213-8587(14)70113-5.
- Shu L, Huang K. Effect of vitamin D supplementation on blood pressure parameters in patients with vitamin deficiency: a systematic review and meta-analysis. J. Am. Soc. Hypertens. 2018;12(7):488–496. doi: 10.1016/j.jash.2018.04.009.
- Schulz KF, Altman DG, Moher D, CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann. Intern. Med. 2010;152(11):726–732. doi: 10.7326/0003-4819-152-11-201006010-00232.
- World Medical Association Ethical principles for medical research involving human subjects, 64th WMA General Assembly, Fortaleza, Brazil. JAMA. 2013;310(20):2191–2194. doi: 10.1001/jama.2013.281053.
- Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–1252. doi: 10.1161/01.HYP.0000107251.49515.c2.
- O’Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322:531–536. doi: 10.1136/bmj.322.7285.531.
- Staessen JA, Bieniaszewski L, O’Brien E, et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The “Ad Hoc” Working Group. Hypertension. 1997;29:30–39. doi: 10.1161/01.HYP.29.1.30.
- Fagard RH. Dipping pattern of nocturnal blood pressure in patients with hypertension. Expert Rev. Cardiovasc. Ther. 2009;7(6):599–605. doi: 10.1586/erc.09.35.
- Moreira JSR, Paula TP, Sperb LF, Miller MEP, Azevedo MJ, Viana LV. Association of plasma vitamin D status with lifestyle patterns and ambulatory blood pressure monitoring parameters in patients with type 2 diabetes and hypertension. Diabetes Res Clin. Pract. 2018;139:139–146. doi: 10.1016/j.diabres.2018.02.038.
- Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet. Med. 2008;25:320–325. doi: 10.1111/j.1464-5491.2007.02360.x.
- Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289(19):2534–2544. doi: 10.1001/jama.289.19.2534.
- Fan HQ, Li Y, Thijs L, et al. International database on ambulatory blood pressure in relation to cardiovascular outcomes investigators: prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J. Hypertens. 2010;28(10):2036–2045. doi: 10.1097/HJH.0b013e32833b49fe.
- Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2015;162(3):192–204. doi: 10.7326/M14-1539.
- Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N. Engl. J. Med. 2003;348(24):2407–2415. doi: 10.1056/NEJMoa022273.
- Banegas JR, Ruilope RM, de la Sierra A, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N. Engl. J. Med. 2018;378:1509–1520. doi: 10.1056/NEJMoa1712231.
- Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N. Engl. J. Med. 2002;347(11):797–805. doi: 10.1056/NEJMoa013410.
- Leitao CB, Canani LH, Kramer CK, et al. Blood pressure means rather than nocturnal dipping pattern are related to complications in type 2 diabetic patients. Diabet. Med. 2008;25:308–313. doi: 10.1111/j.1464-5491.2007.02354.x.
- Mehta R, Drawz PE. Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease? Curr. Hypertens. Rep. 2011;13(5):378–385. doi: 10.1007/s11906-011-0217-8.
- Mehrotra R, Kermah DA, Salusky IB, et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009;76:977–983. doi: 10.1038/ki.2009.288.
- Witham MD, Dove FJ, Dryburgh M, et al. The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomized controlled trial. Diabetologia. 2010;53:2112–2119. doi: 10.1007/s00125-010-1838-1.
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018;71(6):e13–e115.
- Nasri H, Behradmanesh S, Ahmadi A, Rafieian-Kopaeiet M. Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients: a randomized, double-blind, placebo controlled clinical trial. J. Nephropathol. 2014;3:29–33.
- Shab-Bidar S, Neyestani TR, Djazayery A, et al. Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med. 2009;9:125–135. doi: 10.1186/1741-7015-9-125.
- Loh HH, Lim LL, Yee A, Loh HS. Vethakkan SR Effect of vitamin D replacement in primary hyperparathyroidism with concurrent vitamin D deficiency: a systematic review and meta-analysis. Minerva Endocrinol. 2019;44(2):221. doi: 10.23736/S0391-1977.17.02584-6.
- Al-Ali H, Fuleihan GE. Nutritional osteomalacia: substantial clinical improvement and gain in bone density posttherapy. J. Clin. Densitom. 2000;3(1):97. doi: 10.1385/JCD:3:1:097.
Source: PubMed